| Oral submucous fibrosis--treatment with hyalase. | |
| | |
MedLine Citation:
|
PMID: 3968475 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Oral Submucous Fibrosis (OSMF) is a disease of unknown etiology. A total of 96 patients with Oral Submucous Fibrosis have received four regimens of treatment--local dexamethasone, local hyaluronidase, local combination of dexamethasone and hyaluronidase, and local placental extract. The patients were followed up for a period varying from 3 months to 2 years. The group of patients receiving hyaluronidase alone showed quicker improvement in symptoms although its combination with dexamethasone gave somewhat better longer-term results. A new regimen for the treatment of submucous fibrosis is recommended. |
| | |
Authors:
|
P K Kakar; R K Puri; V P Venkatachalam |
Related Documents
:
|
16224155 - A korean predictive model for postoperative nausea and vomiting. 23325085 - Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal c... 8265095 - Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute eme... 14738685 - Use of anti-emetics after intragastric balloon placement: experience with three differe... 19834635 - One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine ... 15613875 - Hair removal using intense pulsed light (epilight): patient satisfaction, our experienc... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of laryngology and otology Volume: 99 ISSN: 0022-2151 ISO Abbreviation: J Laryngol Otol Publication Date: 1985 Jan |
Date Detail:
|
Created Date: 1985-03-19 Completed Date: 1985-03-19 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8706896 Medline TA: J Laryngol Otol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 57-9 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Dexamethasone
/
administration & dosage,
therapeutic use* Drug Therapy, Combination Humans Hyaluronoglucosaminidase / administration & dosage, therapeutic use* Mouth Diseases / drug therapy* Oral Submucous Fibrosis / drug therapy* Placental Extracts / therapeutic use Random Allocation Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Placental Extracts; 50-02-2/Dexamethasone; EC 3.2.1.35/Hyaluronoglucosaminidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mucocoeles of the maxillary antrum. Description, case reports and review of the literature.
Next Document: Microsurgical reconstruction of the trachea in rats (an experimental study).